E-Mail
A team of neuroscientists has identified a potential means to address the loss of cognitive function due to Alzheimer s disease by targeting protein synthesis in mice. Their findings, reported in the journal
Science Signaling, reveal that synthetic pharmaceuticals could rescue the activity of brain cells needed for memory formation. This work is the first to show that reversing impaired protein synthesis in brains afflicted by Alzheimer s disease through a pharmacological approach is not only feasible, but also effective, explains Mauricio Martins-Oliveira, a postdoctoral researcher at New York University s Center for Neural Science and the paper s lead author.
Currently, treatments for Alzheimer s disease center on the reduction of phenomena linked to the affliction, such as amyloid plaque load, neurofibrillary tangles, and neuroinflammation; the
Casi imposible saber quién se vacunó
orlandosentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orlandosentinel.com Daily Mail and Mail on Sunday newspapers.
Gaps in Data Make It Impossible to Know Who Got the Vaccine
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
By Rachana Pradhan, Fred Schulte, Kaiser Health News
Jan 28, 2021
As they rush to vaccinate millions of Americans, health officials are struggling to collect critically important information such as race, ethnicity and occupation of every person they jab.
The data being collected is so scattered that there’s little insight into which health care workers, or first responders, have been among the people getting the initial vaccines, as intended or how many doses instead have gone to people who should be much further down the list.
The gaps which experts say reflect decades of underfunding of public health programs could mean that well-connected people and health personnel who have no contact with patients are getting vaccines before front-line workers, who are at much higher risk for illness. Federal and state officials prioritized health workers plus residents and staffs of nursing homes for the first wave of shots.
Huge gaps in vaccine data make it next to impossible to know who got the shots
As they rush to vaccinate millions of Americans, health officials are struggling to collect critically important information such as race, ethnicity and occupation of every person they jab.
The data being collected is so scattered that there s little insight into which health care workers, or first responders, have been among the people getting the initial vaccines, as intended or how many doses instead have gone to people who should be much further down the list.
The gaps which experts say reflect decades of underfunding of public health programs could mean that well-connected people and health personnel who have no contact with patients are getting vaccines before front-line workers, who are at much higher risk for illness. Federal and state officials prioritized health workers plus residents and staffs of nursing homes for the first wave of shots.